Basics Glaukos Corporation Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. IPO Date: June 25, 2015 Sector: Healthcare Industry: Medical Instruments and Equipment Market Cap: $6.25B Activated in VL: True Average Daily Range Avg Daily Range: $1.15 | 2.02% Avg Daily Range (30 D): $1.85 | 1.96% Avg Daily Range (90 D): $1.76 | 1.98% Institutional Daily Volume Avg Daily Volume: .48M Avg Daily Volume (30 D): .94M Avg Daily Volume (90 D): .85M Trade Size Avg Trade Size (Sh.): 68 Avg Trade Size (Sh.) (30 D): 49 Avg Trade Size (Sh.) (90 D): 49 Institutional Trades Total Inst.Trades: 5,947 Avg Inst. Trade: $3M Avg Inst. Trade (30 D): $4.85M Avg Inst. Trade (90 D): $4.57M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.32M Avg Closing Trade (30 D): $11.87M Avg Closing Trade (90 D): $10.47M Avg Closing Volume: 60.51K     News Sep 4, 2025 @ 5:30 AM Nicox prévoit de rembourser intégralement se... Source: Nicox Sa Sep 4, 2025 @ 5:30 AM Nicox Expects to Fully Repay Financial Debts with ... Source: Gavin Spencer Sep 11, 2024 @ 6:20 PM Glaukos Stocks Rides on Strong Product Demand Amid... Source: Zacks Jul 16, 2024 @ 2:30 PM Will WATCHMAN Sales Aid Boston Scientific's (BSX) ... Source: N/A Jul 16, 2024 @ 2:06 PM Truist lifts Glaukos shares target, highlights str... Source: Emilio Ghigini Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.54 $-.28 $-.34 Diluted EPS $-1.54 $-.28 $-.34 Revenue $ 469.82M $ 133.54M $ 124.12M Gross Profit $ 361.14M $ 104.71M $ 97.22M Net Income / Loss $ -87.61M $ -16.23M $ -19.66M Operating Income / Loss $ -88.4M $ -16.37M $ -22.69M Cost of Revenue $ 108.68M $ 28.83M $ 26.9M Net Cash Flow $ -1.49M $ -8.82M $ -11.56M PE Ratio